<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02328976</url>
  </required_header>
  <id_info>
    <org_study_id>13 197 02</org_study_id>
    <nct_id>NCT02328976</nct_id>
  </id_info>
  <brief_title>Hypothalamus Connectivity in Chronic and Episodic Migraine</brief_title>
  <acronym>HYPOTHAMIG</acronym>
  <official_title>Hypothalamus Connectivity in Chronic and Episodic Migraine in Headache-free Period: A Resting State Functional Magnetic Resonance Imaging Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to compare, using functional magnetic resonance imagery in resting-state, the&#xD;
      connectivity of the hypothalamus in 2 groups of migraineurs. The first group is composed of&#xD;
      chronic migraineurs, studied outside a migraine attack and is compared to gender- and age-&#xD;
      matched episodic migraineurs with very few attacks per month and studied in the attack-free&#xD;
      period. The primary outcome will be the connectivity index of the hypothalamus to brainstem&#xD;
      areas activated during migraine attacks and to the trigeminal-cervical complex.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Functional magnetic resonance imagery allows identification of correlations during rest&#xD;
      between remote brain areas (functional connectivity) through their highly correlated&#xD;
      low-frequency spontaneous fluctuations. This technique is interesting because it is&#xD;
      atraumatic, takes place in resting condition, without administration of substances. Only one&#xD;
      study of connectivity with functional magnetic resonance imagery in resting state, in&#xD;
      headache-free period of migraine, has shown differences in the connection of the&#xD;
      periaqueductal gray matter to the pain matrix in migraineurs and controls. Our region of&#xD;
      interest is the hypothalamus because our group demonstrated activation in this area during&#xD;
      migraine attacks and we hypothesised that the hypothalamus could trigger migraine attacks. We&#xD;
      want to compare 2 groups of migraineurs. The first group is composed of chronic migraineurs&#xD;
      with &gt;15 days with headache per month, compared to the 2nd group composed of age- and&#xD;
      gender-matched episodic migraineurs with &lt; 4 days of migraine per month, without prophylactic&#xD;
      treatment. Our purpose is to study the connectivity of the hypothalamus to midbrain and pons&#xD;
      areas activated in previous studies using positon emission tomography (PET) in spontaneous&#xD;
      migraine attacks. The connectivity of the hypothalamus with the trigeminal-cervical complex,&#xD;
      conveying the pain from cranial vasculature and dura-mater playing a major role in migraine&#xD;
      attack, has never been studied before, mainly for anatomical reasons. Our secondary purpose&#xD;
      is to study the connectivity of the hypothalamus with the pain matrix and the possible&#xD;
      correlations with depression, allodynia and attack treatment overuse.&#xD;
&#xD;
      The primary outcome is the connectivity index of the hypothalamus to the midbrain and pons&#xD;
      area known to be activated in migraine attacks and the trigeminal-cervical complex The&#xD;
      secondary outcome is the connectivity index of the hypothalamus with the pain matrix&#xD;
      (thalamus, sensitive-motor cortex, cingular cortex) This study is a comparative monocentric&#xD;
      pathophysiological study of patients with migraine.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2014</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>connectivity index measure</measure>
    <time_frame>3 months</time_frame>
    <description>connectivity between hypothalamus and nociception areas</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Chronic Migraine</condition>
  <arm_group>
    <arm_group_label>chronic migraineurs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>functional Magnetic Resonance Imaging (fMRI) analysis to compare connectivity of hypothalamus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Episodic migraineurs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>functional Magnetic Resonance Imaging (fMRI) analysis to compare connectivity of hypothalamus</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>functional Magnetic Resonance Imaging (fMRI)</intervention_name>
    <description>both chronic and episodic patients with migraine have a specific functional Magnetic Resonance Imaging (fMRI)</description>
    <arm_group_label>Episodic migraineurs</arm_group_label>
    <arm_group_label>chronic migraineurs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  patients fulfilling international criteria of chronic migraine (with or without&#xD;
             medication overuse)&#xD;
&#xD;
          -  age 18-65 years,&#xD;
&#xD;
          -  with or without migraine prophylactic treatment (unchanged for 3 months). Inclusion&#xD;
             criteria of patients with episodic migraine are: age- and- gender matched patients,&#xD;
             fulfilling international criteria: migraine without aura, with 4 days with&#xD;
             migraine/month, without prophylactic treatment, without history of chronic migraine&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  evolutive severe coexistent chronic disease,&#xD;
&#xD;
          -  MRI contra-indications&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nelly FABRE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31052</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Denuelle M, Fabre N. Functional neuroimaging of migraine. Rev Neurol (Paris). 2013 May;169(5):380-9. doi: 10.1016/j.neurol.2013.02.002. Epub 2013 Apr 18. Review.</citation>
    <PMID>23602115</PMID>
  </reference>
  <results_reference>
    <citation>Lerebours F, Boulanouar K, Bar√®ge M, Denuelle M, Bonneville F, Payoux P, Larrue V, Fabre N. Functional connectivity of hypothalamus in chronic migraine with medication overuse. Cephalalgia. 2019 Jun;39(7):892-899. doi: 10.1177/0333102419833087. Epub 2019 Mar 5.</citation>
    <PMID>30836766</PMID>
  </results_reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>February 25, 2014</study_first_submitted>
  <study_first_submitted_qc>December 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2014</study_first_posted>
  <last_update_submitted>November 9, 2020</last_update_submitted>
  <last_update_submitted_qc>November 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

